Research consultancy services

Description

In order to successfully deliver the ATIMP clinical trials that we run, support from a variety of ancillary services (including biometrics, Pharmacovigilance, central labs etc.) is essential. Cell & Gene Therapy therefore by way of this procurement exercise are seeking to appoint a framework agreement comprising of 6 lots; Lot 1 Biometrics Phase 1 & 2 — small to medium size ATIMP Lot 2 Central Laboratory requirements Lot 3 Clinical Services Lot 4 Pharma-covigilance Lot 5 Translation Services Lot 6 Bespoke Service Providers Please note lot 6 is for only appointed suppliers who cannot fulfil the whole requirements of lot 1-5 but are able to offer some bespoke elements of the relevant lot(s) specification requirements. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years witht he option to extend for an additional 12 months. This is a Framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for an additional 12 months. This is a framework agreement for the duration of 3 years with the option to extend for a further 12 months.